“…An increased prevalence of MED (up to 10 times greater than that found in blood donors) has been reported in lymphoproliferative and gastrointestinal malignant neoplastic diseases, as well as in patients with autoimmune disease ( Markey et al , 1990,1993 ). MED is a familial trait and has been demonstrated in 46% of members in affected families ( Markey et al , 1986,1987,1990 ; Bell et al , 1992 ; Hull et al , 1998 ). The patterns of inheritance suggest that the trait is predominantly an autosomal dominant characteristic ( Fig 2).…”